Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Loftin, Charles D.
Trivedi, Darshini B.
and
Langenbach, Robert
2002.
Cyclooxygenase-1–selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus.
Journal of Clinical Investigation,
Vol. 110,
Issue. 4,
p.
549.
Wyatt, Paul G.
Allen, Michael J.
Chilcott, Josie
Gardner, Christopher J.
Livermore, David G.
Mordaunt, Jackie E.
Nerozzi, Fabrizio
Patel, Mamta
Perren, Marion J.
Weingarten, Gordon G.
Shabbir, Shalia
Woollard, Patrick M.
and
Zhou, Ping
2002.
Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives.
Bioorganic & Medicinal Chemistry Letters,
Vol. 12,
Issue. 10,
p.
1405.
Loftin, Charles D.
Trivedi, Darshini B.
and
Langenbach, Robert
2002.
Cyclooxygenase-1–selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus.
Journal of Clinical Investigation,
Vol. 110,
Issue. 4,
p.
549.
Loftin, Charles D.
Trivedi, Darshini B.
and
Langenbach, Robert
2002.
Cyclooxygenase-1–selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus.
Journal of Clinical Investigation,
Vol. 110,
Issue. 4,
p.
549.
Terzidou, Vasso
and
Bennett, Phillip R.
2002.
Preterm labour.
Current Opinion in Obstetrics and Gynecology,
Vol. 14,
Issue. 2,
p.
105.
Blanks, Andrew M.
and
Thornton, Steven
2003.
The role of oxytocin in parturition.
BJOG: An International Journal of Obstetrics & Gynaecology,
Vol. 110,
Issue. s20,
p.
46.
Cirillo, Rocco
Gillio Tos, Enrico
Schwarz, Matthias K.
Quattropani, Anna
Scheer, Alexander
Missotten, Marc
Dorbais, Jerôme
Nichols, Anthony
Borrelli, Francesco
Giachetti, Claudio
Golzio, Lucia
Marinelli, Paolo
Thomas, Russell J.
Chevillard, Claude
Laurent, Florence
Portet, Karine
Barberis, Claude
and
Chollet, André
2003.
Pharmacology of (2S,4Z)-N-[(2S)-2-Hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2′-methyl[1,1′-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a New Potent and Selective Nonpeptide Antagonist of the Oxytocin Receptor.
Journal of Pharmacology and Experimental Therapeutics,
Vol. 306,
Issue. 1,
p.
253.
McAnulty, Peter A.
and
Burns, Lorna M.
2004.
Evaluation of the maternal and neonatal effects of the oxytocin antagonist, atosiban, in a cross-fostering study in rats.
Reproductive Toxicology,
Vol. 19,
Issue. 1,
p.
65.
Reversi, Alessandra
Rimoldi, Valeria
Marrocco, Tiziana
Cassoni, Paola
Bussolati, Giovanni
Parenti, Marco
and
Chini, Bice
2005.
The Oxytocin Receptor Antagonist Atosiban Inhibits Cell Growth via a “Biased Agonist” Mechanism.
Journal of Biological Chemistry,
Vol. 280,
Issue. 16,
p.
16311.
Griffante, Cristiana
Green, Andrew
Curcuruto, Ornella
Haslam, Carl P
Dickinson, Bryony A
and
Arban, Roberto
2005.
Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist.
British Journal of Pharmacology,
Vol. 146,
Issue. 5,
p.
744.
Richter, Oliver N.
Dorn, C.
van de Vondel, P.
Ulrich, U.
and
Schmolling, J.
2005.
Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
Archives of Gynecology and Obstetrics,
Vol. 272,
Issue. 1,
p.
26.
Bisits, Andrew M
Smith, Roger
Mesiano, Sam
Yeo, George
Kwek, Kenneth
MacIntyre, David
Chan, Eng C
and
Bourne, Philip
2005.
Inflammatory Aetiology of Human Myometrial Activation Tested Using Directed Graphs.
PLoS Computational Biology,
Vol. 1,
Issue. 2,
p.
e19.
Salonia, Andrea
Nappi, Rossella E.
Pontillo, Marina
Daverio, Rita
Smeraldi, Antonella
Briganti, Alberto
Fabbri, Fabio
Zanni, Giuseppe
Rigatti, Patrizio
and
Montorsi, Francesco
2005.
Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women.
Hormones and Behavior,
Vol. 47,
Issue. 2,
p.
164.
Mueller, Andreas
Maltaris, Theodoros
Siemer, Joern
Binder, Helge
Hoffmann, Inge
Beckmann, Matthias W.
and
Dittrich, Ralf
2006.
Uterine contractility in response to different prostaglandins: results from extracorporeally perfused non-pregnant swine uteri.
Human Reproduction,
Vol. 21,
Issue. 8,
p.
2000.
Mueller, A.
Siemer, J.
Schreiner, S.
Koesztner, H.
Hoffmann, I.
Binder, H.
Beckmann, M.W.
and
Dittrich, R.
2006.
Role of estrogen and progesterone in the regulation of uterine peristalsis: results from perfused non-pregnant swine uteri.
Human Reproduction,
Vol. 21,
Issue. 7,
p.
1863.
Rang, HP
Dale, MM
Ritter, JM
and
Flower, RJ
2007.
Rang &amp Dale's Pharmacology.
p.
445.
Donders, Gilbert G.G.
Van Keirsbilck, Joachim
De Roo, Toon
Schreven, Liesbeth
and
Hanssens, Myriam
2008.
Non-cardiogenic lung edema in a woman treated with atosiban for preterm labor.
Journal of Perinatal Medicine,
Vol. 36,
Issue. 5,
Thornton, Steven
Goodwin, Thomas M.
Greisen, Gorm
Hedegaard, Morten
and
Arce, Joan-Carles
2009.
The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial.
American Journal of Obstetrics and Gynecology,
Vol. 200,
Issue. 6,
p.
627.e1.
Goupil, Eugénie
Tassy, Danaë
Bourguet, Carine
Quiniou, Christiane
Wisehart, Veronica
Pétrin, Darlaine
Le Gouill, Christian
Devost, Dominic
Zingg, Hans H.
Bouvier, Michel
Saragovi, Horacio Uri
Chemtob, Sylvain
Lubell, William D.
Claing, Audrey
Hébert, Terence E.
and
Laporte, Stéphane A.
2010.
A Novel Biased Allosteric Compound Inhibitor of Parturition Selectively Impedes the Prostaglandin F2α-mediated Rho/ROCK Signaling Pathway.
Journal of Biological Chemistry,
Vol. 285,
Issue. 33,
p.
25624.
Magafa, Vassiliki
Borovičková, Lenka
Slaninová, Jiřina
and
Cordopatis, Paul
2010.
Synthesis and biological activity of oxytocin analogues containing unnatural amino acids in position 9: structure activity study.
Amino Acids,
Vol. 38,
Issue. 5,
p.
1549.